BioMerieux SA (BMXMF)
101.91
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
BioMerieux Market Cap: 12.04B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 12.04B |
| May 16, 2024 | 12.04B |
| May 15, 2024 | 12.58B |
| May 14, 2024 | 12.58B |
| May 13, 2024 | 12.58B |
| May 10, 2024 | 12.58B |
| May 09, 2024 | 12.58B |
| May 08, 2024 | 12.58B |
| May 07, 2024 | 12.55B |
| May 06, 2024 | 12.55B |
| May 03, 2024 | 12.55B |
| May 02, 2024 | 12.19B |
| May 01, 2024 | 12.19B |
| April 30, 2024 | 12.49B |
| April 29, 2024 | 12.49B |
| April 26, 2024 | 12.49B |
| April 25, 2024 | 12.49B |
| April 24, 2024 | 12.49B |
| April 23, 2024 | 12.49B |
| April 22, 2024 | 12.41B |
| April 19, 2024 | 12.41B |
| April 18, 2024 | 12.19B |
| April 17, 2024 | 13.12B |
| April 16, 2024 | 13.12B |
| April 15, 2024 | 13.19B |
| Date | Value |
|---|---|
| April 12, 2024 | 12.94B |
| April 11, 2024 | 13.15B |
| April 10, 2024 | 13.23B |
| April 09, 2024 | 13.62B |
| April 08, 2024 | 12.15B |
| April 05, 2024 | 12.15B |
| April 04, 2024 | 12.52B |
| April 03, 2024 | 12.83B |
| April 02, 2024 | 12.83B |
| April 01, 2024 | 12.83B |
| March 28, 2024 | 12.83B |
| March 27, 2024 | 12.83B |
| March 26, 2024 | 12.83B |
| March 25, 2024 | 12.83B |
| March 22, 2024 | 12.83B |
| March 21, 2024 | 12.83B |
| March 20, 2024 | 12.83B |
| March 19, 2024 | 12.83B |
| March 18, 2024 | 12.83B |
| March 15, 2024 | 12.83B |
| March 14, 2024 | 12.83B |
| March 13, 2024 | 12.83B |
| March 12, 2024 | 12.83B |
| March 11, 2024 | 12.83B |
| March 08, 2024 | 12.70B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
8.958B
Minimum
Sep 09 2019
19.98B
Maximum
Oct 12 2020
13.10B
Average
12.59B
Median
Jan 17 2023
Market Cap Benchmarks
| DBV Technologies SA | 112.23M |
| Cellectis SA | 215.14M |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 187.43M |
| Innate Pharma SA | 219.07M |
Market Cap Related Metrics
| PE Ratio | 31.26 |
| PS Ratio | 3.041 |
| Price to Book Value | 2.903 |
| Price to Free Cash Flow | 105.00 |
| Price | 101.91 |
| Earnings Yield | 3.20% |
| Operating PE Ratio | 19.67 |
| Normalized PE Ratio | 24.21 |